Background. Among cardiac tumors myxoma is the most common benign neoplasm. The aim of this study was to review our Institution’s 15-year experience with intracardiac myxoma. Methods. From 1985 through 2001, 38 patients (22 males, 16 females, mean age 57.06 ± 11.1, range 32-74 years) underwent surgical resection of a cardiac myxoma at our Institution. The tumor was located in the left atrium in 29 patients (76.3%), in the right atrium in 8 patients (21%), and in the right ventricle in 1 patient (2.6%). The duration of symptoms prior to surgery ranged from 2 to 30 days. None of the patients had a familial myxoma. The surgical approach comprised complete wide excision in all patients. The incidence of delayed death, thromboembolic complications, valve degeneration, recurrence and reoperation were reviewed and the Kaplan-Meier survival curve was elaborated. Results. There were no perioperative deaths. Three patients (7.9%) developed postoperative neurological sequelae: transient ischemic attacks in 2 patients (5.2%) and a stroke with persistent neurological deficit in 1 patient (2.6%). One patient (2.6%) required pacemaker implantation for complete atrioventricular block. An inferior myocardial infarction occurred in 1 patient (2.6%). During the follow-up, complete in 89.4% of the patients (34 out of 38 patients, mean 96.8 ± 68.4 months, range 1-218 months), there were 2 (5.8%) non-cardiac related deaths. All the patients underwent clinical examination and echocardiography at regular intervals (1 year): no neurological event was observed during the follow-up and 29 patients (90.6%) are in NYHA functional class I. At 15 years the eventfree rate is 85.2%. At 15 years the actuarial survival for the whole group is 92%. Conclusions. At present, the diagnosis of myxoma is easy to make and two-dimensional echocardiography plays a major role in this field. Surgery is the gold standard treatment and the clinical longterm results are excellent.

Il mixoma cardiaco: risultati chirurgici e follow-up clinico a 15 anni / R. Scrofani, C. Carro, L. Villa, M. Botta, C. Antona. - In: ITALIAN HEART JOURNAL. SUPPLEMENT. - ISSN 1129-4728. - 3:7(2002 Jul), pp. 753-758.

Il mixoma cardiaco: risultati chirurgici e follow-up clinico a 15 anni

C. Antona
Ultimo
2002

Abstract

Background. Among cardiac tumors myxoma is the most common benign neoplasm. The aim of this study was to review our Institution’s 15-year experience with intracardiac myxoma. Methods. From 1985 through 2001, 38 patients (22 males, 16 females, mean age 57.06 ± 11.1, range 32-74 years) underwent surgical resection of a cardiac myxoma at our Institution. The tumor was located in the left atrium in 29 patients (76.3%), in the right atrium in 8 patients (21%), and in the right ventricle in 1 patient (2.6%). The duration of symptoms prior to surgery ranged from 2 to 30 days. None of the patients had a familial myxoma. The surgical approach comprised complete wide excision in all patients. The incidence of delayed death, thromboembolic complications, valve degeneration, recurrence and reoperation were reviewed and the Kaplan-Meier survival curve was elaborated. Results. There were no perioperative deaths. Three patients (7.9%) developed postoperative neurological sequelae: transient ischemic attacks in 2 patients (5.2%) and a stroke with persistent neurological deficit in 1 patient (2.6%). One patient (2.6%) required pacemaker implantation for complete atrioventricular block. An inferior myocardial infarction occurred in 1 patient (2.6%). During the follow-up, complete in 89.4% of the patients (34 out of 38 patients, mean 96.8 ± 68.4 months, range 1-218 months), there were 2 (5.8%) non-cardiac related deaths. All the patients underwent clinical examination and echocardiography at regular intervals (1 year): no neurological event was observed during the follow-up and 29 patients (90.6%) are in NYHA functional class I. At 15 years the eventfree rate is 85.2%. At 15 years the actuarial survival for the whole group is 92%. Conclusions. At present, the diagnosis of myxoma is easy to make and two-dimensional echocardiography plays a major role in this field. Surgery is the gold standard treatment and the clinical longterm results are excellent.
Atrial mass; Cardiac surgery; Cardiac tumor; Echocardiography; Myxoma; Primary cardiac tumor.
Settore MED/23 - Chirurgia Cardiaca
lug-2002
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/180661
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 12
  • ???jsp.display-item.citation.isi??? ND
social impact